These findings support the hypothesis that common functional VEGFA polymorphisms modulate VEGF expression and microvascular vulnerability in diabetes, although effects vary by ancestry, diabetes type, and study design—highlighting the need for larger, ethnically diverse cohorts and deeper functional validation. This evidence concerns the gene VEGFA and diabetes mellitus.